Human tumor virus utilizes exosomes for intercellular communication

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 47, 2010, Pages 20370-20375

  Meckes Jr , David G ^a   Shair, Kathy H Y ^a   Marquitz, Aron R ^a   Kung, Che Pei ^b   Edwards, Rachel H ^a   Raab Traub, Nancy ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Herpesvirus; Oncogene

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LATENT MEMBRANE PROTEIN 1; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

CELL COMMUNICATION; CELL GROWTH; CONFERENCE PAPER; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXOSOME; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR VIRUS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 78650553841     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1014194107     Document Type: Article

References (38)

1. Raab-Traub N (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12:431-441.
2. Kaye KM, Izumi KM, Kieff E (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150-9154. (Pubitemid 23306469)
3. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
4. Morris MA, Dawson CW, Young LS (2009) Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol 5:811-825.
5. Miller WE, Earp HS, Raab-Traub N (1995) The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 69:4390-4398.
6. Miller WE, Raab-Traub N (1999) The EGFR as a target for viral oncoproteins. Trends Microbiol 7:453-458.
7. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J (2009) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 106:3794-3799.
8. SkogJ, et al. (2008) Glioblastomamicrovesicles transportRNAandproteins thatpromote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476.
9. Schorey JS, Bhatnagar S (2008) Exosome function: From tumor immunology to pathogen biology. Traffic 9:871-881.
10. Simons M, Raposo G (2009) Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 21:575-581.
11. Mori Y, et al. (2008) Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 9:1728-1742.
12. Keryer-Bibens C, et al. (2006) Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 6:283.
13. Klibi J, et al. (2009) Blood diffusion and Th1-suppressive effects of galectin-9- containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113:1957-1966.
14. Dukers DF, et al. (2000) Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 165:663-670.
15. Ceccarelli S, et al. (2007) Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int J Cancer 121:1494-1506.
16. Houali K, et al. (2007) A new diagnostic marker for secreted Epstein Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin Cancer Res 13:4993-5000.
17. Cheung ST, et al. (1999) Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 83:121-126.
18. Keller S, et al. (2009) Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett 278:73-81.
19. Simpson RJ, Jensen SS, Lim JW (2008) Proteomic profiling of exosomes: Current perspectives. Proteomics 8:4083-4099.
20. Mainou BA, Everly DN, Jr., Raab-Traub N (2007) Unique signaling properties of CTAR1 in LMP1-mediated transformation. J Virol 81:9680-9692.
21. Valadi H, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659.
22. Pegtel DM, et al. (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107:6328-6333.
23. Cai X, et al. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23.
24. Gilligan K, et al. (1990) Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 64:4948-4956.
25. Griffiths GM, Tsun A, Stinchcombe JC (2010) The immunological synapse: A focal point for endocytosis and exocytosis. J Cell Biol 189:399-406.
26. Hurley JH (2008) ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol 20:4-11.
27. de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M (2003) Lipid raft-associated protein sorting in exosomes. Blood 102:4336-4344.
28. Rothenberger S, Burns K, Rousseaux M, Tschopp J, Bron C (2003) Ubiquitination of the Epstein-Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site. Oncogene 22:5614-5618.
29. Wubbolts R, et al. (2003) Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 278:10963-10972.
30. Ardila-Osorio H, et al. (2005) TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1. Int J Cancer 113:267-275.
31. Yasui T, Luftig M, Soni V, Kieff E (2004) Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc Natl Acad Sci USA 101:278-283.
32. Marsh M, Helenius A (2006) Virus entry: Open sesame. Cell 124:729-740.
33. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11:1143-1149.
34. Kung CP, Raab-Traub N (2008) Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. J Virol 82:5486-5493.
35. Shair KH, Schnegg CI, Raab-Traub N (2008) EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res 68:6997-7005.
36. Staubach S, Razawi H, Hanisch FG (2009) Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics 9:2820-2835.
37. Hood JL, Pan H, Lanza GM, Wickline SA; Consortium for Translational Research in Advanced Imaging and Nanomedicine (C-TRAIN) (2009) Paracrine induction of endothelium by tumor exosomes. Lab Invest 89:1317-1328.
38. Edwards RH, Marquitz AR, Raab-Traub N (2008) Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82:9094-9106.